SuperworthImpact Biomedical market cap IBO
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $388.2M
- Highest close in our data
- $1.1B
- Mar 2026
Impact Biomedical is worth $388.2M at the close on Oct 23, 2026, at $3.60 a share.
That is up 329% over the last year.
Its highest close in our data was $1.1B in Mar 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $388.2M | $289M | $1.1B | −41% |
| 2025 | $658.1M | $55.2M | $856.8M | +215% |
| 2024 | $209M | $160.3M | $434M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Impact Biomedical's size, closest first, today.
| Company | Market cap |
|---|---|
| IBOImpact Biomedical | $388.2M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| NATRNatures Sunshine Products | $213.8M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.2B |
| Peer median | $597.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Impact Biomedical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.